The mammalian RUNX family consists of three members: RUNX1, RUNX2 and RUNX3. Members of the RUNX family are DNA-binding proteins that regulate the expression of genes involved in cell differentiation and cell cycle progression. RUNX2 (Runt-related transcription factor 2) is involved in skeletal mineralization by stimulating osteoblast differentiation of mesenchymal stem cells, promoting chondrocyte hypertrophy, and contributing to endothelial cell migration and vascular invasion in developing bones. Mutations in the corresponding RUNX2 gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). RUNX2 is also abnormally expressed in various human cancers, including prostate and breast cancer. It plays an important role in migration, invasion, and bone metastasis of prostate and breast cancer cells.
Clone
MD438
Isotype
IgG1
Host species
Mouse
Species Reactivity
Human, mouse, rat
Cellular Localization
Nucleus
Positive Control
Tonsil, lymph node, spleen, osteosarcoma
Applications
IHC, WB
Intended Use
Research Use Only
![RUNX2 [MD438]](https://medaysis.com/wp-content/uploads/2026/11/RUNX2-MD438-MC0688_human-lymph-node-e1793572620869.jpg)